title: Sodium thiosulfate for the treatment of warfarin-induced calciphylaxis in a nondialysis patient.
abstract: Calciphylaxis or uremic arteriolopathy is a complex process typically seen in patients with end-stage renal disease, but has also been reported in patients with normal renal function. However, therapies for calciphylaxis are based on reports of traditional patients (i.e., end-stage renal disease). A mainstay of therapy, sodium thiosulfate (STS), has been shown to be effective for the treatment of calciphylaxis. Without a standardized therapy reported for nondialysis patients there is a need for evidence-based therapy. Here, we report a case of a 63-year-old woman with an acute injury on chronic kidney disease (CrClBaseline = 48 mL/min, CrClAKI = 36 mL/min), not requiring dialysis, with warfarin-induced calciphylaxis. After 4 weeks of therapy with STS, sevelamer, alendronate, and enzymatic debridement the patient subjectively reported slight improvement of the necrotic ulcers but developed cellulitis on her nonaffected limb. Additionally, after 12 weeks of therapy she was readmitted for renal failure and subsequently required dialysis.
authors.affiliation: Department of Pharmacy Practice, The University of Mississippi School of Pharmacy, Jackson, Mississippi, USA.
authors.forename: Emily J
authors.initials: EJ
authors.lastname: Carrell
authors.affiliation: Department of Pharmacy Practice, The University of Mississippi School of Pharmacy, Jackson, Mississippi, USA.
authors.forename: Allison
authors.initials: A
authors.lastname: Bell
keywords: Calciphylaxis; chronic kidney disease; nondialysis; sodium thiosulfate; warfarin-induced
references.citation: Am J Health Syst Pharm. 2008 Aug 1;65(15):1419-29
references.pmid: 18653812
references.citation: Kidney Blood Press Res. 2013;37(4-5):346-59
references.pmid: 24247072
references.citation: Am J Nephrol. 2011;34(5):460-7
references.pmid: 21986387
references.citation: Int J Gen Med. 2013 Aug 09;6:665-9
references.pmid: 23966800
references.citation: Arch Dermatol. 2009 Apr;145(4):451-8
references.pmid: 19380668
references.citation: Clin Exp Dermatol. 2009 Jan;34(1):39-42
references.pmid: 18627391